TVYCROSS technology is a high concentration of cross-linked hyaluronic acid 25 mg with Lidocain that produces longer lasting, smoother and more natural looking results.
Design to be used to sculpt the chin and jaw area, giving facial definition that can last for up to 24 months.
Cross-linked hyaluronic acid 25mg + Lidocain 0,3%.
|5||10,00 €||Up to 50,00 €|
|10||20,00 €||Up to 200,00 €|
JUVEDERM VOLUX (2x1ml) ALLERGAN
Dispositif Médical only for professional use.
NEW 2019 Allergan launches Juvéderm® VOLUX - the latest evolution in facial filler treatments for those seeking a more defined chin and jawline.
Juvéderm® VOLUX TM is a sterile pyrogen-free physiological solution of cross-linked hyaluronic acid which is not of animal origin.
The gel is presented in a graduated, pre-filled, disposable syringe.
Juvederm Volux is a structural gel that lasts 18 to 24 months, according to Allergan studies.
Juvederm Volux is a hyaluronic acid filler that utilizes the same VYCROSS technology as other products in the Juvederm family such as Voluma, Volbella and Vollure.
VYCROSS technology is a high concentration of cross-linked hyaluronic acid that produces longer lasting, smoother and more natural looking results.
Hyaluronic Acid gel 25 mg
Lidocaine hydrochloride 3 mg
Phosphate buffer pH 7.2 q.s. 1ml
One syringe contains 1 ml of Juvéderm® VOLUX.
Each box contains two 1mL Juvéderm® VOLUXTM syringes, 4 single-use 27G1/2” sterile needles to be used only for injecting Juvéderm® VOLUXTM, an instruction leaflet and a set of labels in order to ensure traceability.
The contents of the Juvéderm® VOLUXsyringes is sterilised by moist heat.
The 27G1/2” needles are sterilised by radiation.
Juvéderm® VOLUX is an injectable implant intended to restore and create volume of the face.
The presence of lidocaine is meant to reduce the patient’s pain during treatment.
Juvéderm® VOLUXTis indicated only for subcutaneous and supraperiostal injections.
The technique and depth of the injection vary depending on the area to be treated.
Medical practitioners must take into account the fact that this product contains lidocaine.
Juvéderm® VOLUXTM is not recommended for intramuscular injections.
Do not inject Juvéderm® VOLUX in the periorbital area (eyelid, under- eye area, crow’s feet), in the glabellar region or in the lips.
Juvéderm® VOLUX is not intended for use in breast augmentation/ reconstruction.
Do not inject into the blood vessels (intravascular). Intravascular injection may lead to embolization, occlusion of the vessels, ischemia or infarction. Do not overcorrect.
Global pharmaceutical company Allergan has launched Juvéderm VOLUX, a hyaluronic acid injectable gel that uses the existing VYCROSS patented technology.
Juvéderm® is the world's leading brand of hyaluronic acid facial fillers.
The fillers work by restoring lost volume in the face, filling lines and wrinkles and hydrating skin – with results that can last from 9-24 months,depending on the treatment chosen.
This new filler is FDA-approved to re-sculpt the chin and jawline.
Juvéderm® VOLUX is a brand of CE marked medical approved to restore and create volume in the chin and jaw area.
Allergan headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercialising branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.